Canada's plan to sell generic drugs to developing countries is threatenedBMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7442.728-d (Published 25 March 2004) Cite this as: BMJ 2004;328:728
- David Spurgeon
The Canadian HIV/AIDS Legal Network has posted an urgent action alert on its website asking Canadians to write to Prime Minister Paul Martin by 22 March demanding amendments to a bill before parliament concerning the sale of generic drugs to developing countries www.aidslaw.ca/. The network maintains that the bill as it stands will prevent manufacturers of generic drugs from selling them to poor countries to fight diseases such as AIDS, malaria, and tuberculosis.
“Unless amended, Bill C-9 will not lead to cheaper medicines for people most in need,” the website says.
Bill C-9 was first introduced in November 2003 as Bill C-56 (BMJNews extra 2003;327:832) and was reinstated in February 2004. Its purpose …
Log in using your username and password
Log in through your institution
Sign up for a free trial